Tests royal jelly in adults with high blood pressure
Tests royal jelly against placebo for inflammation in adults with high blood pressure.
Plain-language title generated from the registry record
Registry title: Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
Key facts
- Where
- Rio de Janeiro, BrazilSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 75 with stage 1 high blood pressure who have been on regular treatment for more than 6 months.
- Age
- 18 Years to 75 Years
- Sex
- All sexes can join.
- Disease stage
- Stage 1 high blood pressure (hypertension).
- Earlier treatment
- Regular treatment for more than 6 months, with no change in medication doses in the last 3 months.
Main reasons for not taking part
- Autoimmune, infectious, liver or chronic kidney disease, diabetes, cancer or AIDS
- Pregnant women
- Use of antioxidant vitamin supplements, prebiotics, probiotics or synbiotics
- Habitual intake of royal jelly or allergy to bee stings
- Acute myocardial infarction or stroke
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06917131, who can take part
Where in Brazil
- Denise mafraRio de Janeiro, BrazilContact: Ludmila Cardozo, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Universidade Federal Fluminense
- Trial code
- NCT06917131
- Record updated
- 19 May 2026
- Original description
The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.Read full original descriptionShow less
Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
Inclusion: Diagnosis of stage 1 hypertension; Regular treatment for more than 6 months; No changes in medication doses during the last 3 months.
Exclusion: Use of catabolic drugs or antibiotics; Autoimmune diseases; Infectious diseases; Diabetes; Chronic kidney disease; Liver disease; Cancer; Allergy to bee stings; Acute myocardial infarction (AMI); Stroke (CVA); AIDS; Pregnant women; Use of antioxidant vitamin supplements, prebiotics, probiotics, or synbiotics; Habitual intake of royal jelly.